with spectrophotometry. Hence, the absorbed dose (D) is given by: D = A λ · c λ where A λ is the absorbance (λ is 395 or 603 nm) and c λ is a constant which depends on the radiolytic yield (i.e. the amount of radicals created per absorbed joule), the density, and the molar extinction coefficient of the solution, as well as the path length of the light through the solution. The reproducibility of the MV dose measurements was assessed by irradiating samples of MV solution (introduced in optical cuvettes) with 1000 monitor units (MU) from a clinical electron beam (4 MeV at an Elekta Synergy) and repeating this process for 20 different solutions. The linearity response was checked by delivering 10 -10 000 MU to the solution, while the dose-rate dependence was investigated at normal clinical dose-rates by delivering 1 000 MU with varying doserate 25 -430 MU/min. Results: Our MV dose measurements show an acceptable level of reproducibility with a standard deviation for the 20 measurements of 1.8 % for both wavelengths. The dosimeter has a linear dose-response relationship between 500 -7 000 MU (≈ 5 -70 Gy), and is clinically usable (but not linear) down to 100 MU, see Figure 1 .
Our results show a small dose-rate dependence of the MV response, specifically an increase of the response with higher dose-rate. This behavior is most likely due to the fading of the signal that occurs over time and starts to become a considerable factor for long irradiation sessions.
Conclusions:
The results of our study show that MV is useable as a clinical dosimeter within radiotherapy. Although its characteristics cannot rival those of ion-chambers or diodes at normal dose-rates, its reported dose-rate independence up to high dose-rates makes it of clinical interest. The characteristics of MV can make it a vital component in taking promising experimental radiotherapy techniques like high dose rate irradiation and synchrotron radiation therapy to clinical trials. Purpose/Objective: To present a simplified methodology for quantitatively assessing the effects of spatial dose delivery inaccuracies on DVHs and to highlight the dependence of the treatment outcome and patient safety on small spatial dose delivery errors in an hypophysis treatment case. Materials and Methods: The planning-CT scans, the RStructure dicom-RT file and the Treatment Planning System (TPS) calculated RDose dicom-RT file of an hypophysis patient treatment were imported to the open source software 3Dslicer. Spatial dose delivery errors, ranging from 1 to 3 mm in all Cartesian directions, were systematically introduced to the TPS calculated dose dataset (RDose). To achieve this, the RDose dataset volume was manually moved along the x, y and z axes (antero-posterior, left-right and cranio-caudal directions respectively) while keeping spatially stationary the planning-CT scans and RStructure datasets. The DVHs, D mean , D min . D max , V 50.4 and D 95% for the PTV, brainstem, right optic nerve and left optic nerve were calculated for the nominal dose delivery scenario, as well as for various simulation scenarios representing different spatial dose delivery errors. Results: For the brain tumor radiotherapy case studied (hypophysis), a relatively small spatial dose delivery error of 1 mm in each axis resulted in minor DVH alterations for all structures. Contrarily, the worst case scenario investigated, i.e., 3 mm spatial dose delivery error in each axis, resulted in important DVH alterations for the PTV and the organs at risk. In the latter scenario, PTV D 95% was reduced by about 18%, while right optic nerve D 95% was increased by over 30%. Acquired results suggest that cranio-caudal spatial errors induce the more intense DVH alterations. The incorporated table presents the calculated values of D mean , D min . D max , V 50.4 and D 95% for all studied structures and two of the simulated scenarios with spatial delivery inaccuracies, whilst corresponding PTV DVHs are depicted in the included Figure  ( solid, dashed and dotted lines represent the scenarios of 0, 1 and 3 mm spatial errors in each axis, respectively).
The accuracy of the spatial deposition of the 3D dose pattern in brain tumor radiotherapy is strongly correlated to treatment outcome and patient safety. In the hypophysis treatment simulated, the combined effect of 3 mm spatial inaccuracy in each direction can significantly alter the DVHs of the target and the organs at risk. The proposed methodology, which employs the planning-CT scans, the RStructure and RDose dicom-RT files as well as the open source software 3D-slicer, can be used for quantifying the effect of spatial errors on dose delivery accuracy in any selected treatment site and/or treatment plan. This simplified approach could be used in the appraisal of the quality and robustness of a specific clinical treatment plan or for plan intercomparison with regard to the relative sensitivity of dosimetric outcome to spatial uncertainties.
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Hospital neutron dosimetry studied using diamond detectors F. Manchado de Sola 1 , L. Acosta 2 , J.A. Dueñas 2 , I. Martel 2 1 Juan Ramón Jiménez Hosp & Huelva University, Medical Physics Department & Applied Physics, Huelva, Spain 2 Huelva University, Applied Physics, Huelva, Spain Purpose/Objective: Diamond detectors are used in fundamental nuclear physics and many others fields of applied science. Its radiation hardness and electrical properties make them ideal to work under extreme conditions. The main goal of this work is to study the advantages of using diamond detectors as neutron dosimeter for both protontherapy and conventional radiotherapy accelerators. Materials and Methods: a) Neutron from a 252 Cf source: The diamond detector was mounted inside a reaction chamber close to a 252 Cf source. A shielding of 3.2 mm of lead was placed between detector and source to avoid heavy products deposition. b) Neutrons from a conventional radiotherapy accelerator: Measurements were performed using the 15 MV photons mode at the Juan Ramón Jímenez Hospital radiotherapy accelerator. In order to minimize the photon radiation all collimators were closed and diamond detector was shielded with lead. c) Neutron produced in a reaction scenario at a 3 MV Tandem:
The experiment took place at the Centro Nacional de Aceleradores (CNA) in Sevilla. Neutrons produced by a 12 C( 2 H,n) 13 N reaction were detected outside the reaction chamber by our diamond detector placed 0º off the beam axis by the target position. Results: After 40 days non-stop measurement with the 252 Cf source, the expected elastic collision ramp due to elastically scattered neutrons was observed an activation peak was observed too. Similarly, our single crystal diamond detector placed alongside the radiotherapy accelerator showed the expected shape too. At the CNA Tandem, the analogous shape was obtained at the forward diamond detector. Several peaks due to charged particles at the 90º diamond detector were observed in a monitor system in vacuum. Good agreement between experimental data and simulations has been achieved. Conclusions: Our experimental setup is ready to detect neutrons coming from different sources. Diamond detector is showing a promising behavior in neutron detection devoted to measurement at medical facilities. Simulations generated with GAMOS-GEANT4 show a good agreement with experimental data.
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Experimental evaluation of high density ArcCHECK mode for SBRT verification E. Montes 1 , I. Modolell 1 , R. De Blas 1 , I. Sancho 1 , J. Puxeu 1 , G. Reynés 1 , C. Picon 1 1 ICO Hospitalet, Physics, Barcelona, Spain Purpose/Objective: Stereotactic body radiation therapy (SBRT) is a type of radiation therapy in which the dose is delivered to small, well-defined tumors using a high dose per fraction scheme. Our centre uses the ArcCHECK phantom manufactured by Sun Nuclear (SNC Melbourne, FL) to perform the pre-treatment verification of IMRT and VMAT plans. The ArcCHECK features a High Density (HD) measurement procedure in which the measurement resolution is doubled. The purpose of the present work is to evaluate whether this HD mode is required for pre-treatment QA of our SBRT plans. Materials and Methods: Ten different SBRT (VMAT) plans were calculated with Varian Eclipse treatment planning system (TPS) using the analytical anisotropic algorithm (AAA version 10.0.28). The plans were made for a TrueBeam linear accelerator (Varian Medical Systems, Palo Alto, CA), with 6 MV arcs using either a Flattening Filter (FF) or a Flattening Filter-Free (FFF) configuration. The degree of modulation
